MTST (MetaStat) Interest Expense: $-0.12 Mil (TTM As of Feb. 2018)


What is MetaStat Interest Expense?

MetaStat MTST Interest Expense is $-0.12 Mil as of Feb. 2018.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. MetaStat's interest expense for the three months ended in Feb. 2018 was $ -0.03 Mil. Its interest expense for the trailing twelve months (TTM) ended in Feb. 2018 was $-0.12 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. MetaStat's Operating Income for the three months ended in Feb. 2018 was $ -0.88 Mil. MetaStat's Interest Expense for the three months ended in Feb. 2018 was $ -0.03 Mil. MetaStat did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

MetaStat  (OTCPK:MTST) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

MetaStat's Interest Expense for the three months ended in Feb. 2018 was $-0.03 Mil. Its Operating Income for the three months ended in Feb. 2018 was $-0.88 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Feb. 2018 was $0.00 Mil.

MetaStat's Interest Coverage for the quarter that ended in Feb. 2018 is calculated as

MetaStat did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

MetaStat Interest Expense Historical Data

* Premium members only.

The historical data trend for MetaStat's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaStat Interest Expense Chart

MetaStat Annual Data
Trend Feb09 Feb10 Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.14 -0.63 -0.32 -1.06 -0.12

MetaStat Quarterly Data
May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.08 -0.03 -0.03 -0.03 -0.03

MetaStat Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Feb. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.12 Mil mean?
MetaStat (MTST) has a Interest Expense of $-0.12 Mil as of Feb. 2018. Interest Expense is the amount a company pays on its long-term debt. View historical data on MetaStat and its competitors.
Is MetaStat's Interest Expense too high?
MetaStat's current Interest Expense is $-0.12 Mil.
How does MetaStat's Interest Expense compare to OBMP and NSPX?
MetaStat's Interest Expense of $-0.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on MetaStat and its competitors. MetaStat's current Interest Expense is $-0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaStat stock overvalued right now?
MetaStat (MTST) has a current Interest Expense of $-0.12 Mil. The current Interest Expense is $-0.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For MetaStat (MTST), the current Interest Expense is $-0.12 Mil as of Feb. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaStat Business Description

Address 27 Drydock Avenue, 2nd Floor, Boston, MA, USA, 02210
MetaStat Inc is a us-based biotechnology company which focuses on discovering and developing personalized therapeutic (Rx) and diagnostic (Dx) treatment solutions for cancer patients. The company focuses on development programs of the novel therapeutic product candidates that target the Mena protein isoform whereas the Companion Diagnostics program is focused on developing companion tests to be used in combination with cancer drugs, that provide essential information for the safe and effective use of a corresponding drug or biological product to improve patient outcome. It also develops a prognostic diagnostic program which is focused on developing diagnostic tests that predict the risk of future metastasis in cancer patients following the initial treatment of their primary tumor.